Main Session
Sep
30
SS 40 - Hem 2: New Protocols, New Paradigms: Clinical Trials Shaping the Future of Hematologic RT
330 - Pembrolizumab and Involved Site Radiation Therapy Alone as an Alternative to Transplant in Patients with Localized Failure following Chemotherapy for Hodgkin Lymphoma: A Prospective Multicenter Phase
Presenter(s)
Alexandra Dreyfuss, MD, MS - Memorial Sloan Kettering Cancer Center, New York, NY